Literature DB >> 15857929

Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.

Matthew C Kiernan1, Arun V Krishnan, Cindy S-Y Lin, David Burke, Samuel F Berkovic.   

Abstract

To determine the effect of an established mutation of the beta1 subunit of Na(+) channels on nerve excitability, studies were undertaken in patients diagnosed with generalized epilepsy with febrile seizures plus (GEFS+). Multiple nerve excitability measurements were used to investigate the membrane properties of sensory and motor axons in five patients (aged 18-55 years) who were currently experiencing no seizures and were not on anticonvulsants. There was no history of paraesthesiae, fasciculation or cramps to suggest hyperexcitability of peripheral nerve axons. The median nerve was stimulated at the wrist, and compound muscle action potentials (CMAPs) were recorded from abductor pollicis brevis and the antidromic compound sensory nerve action potential (CSAPs) from digit 2. Stimulus-response behaviour, strength-duration time constant, threshold electrotonus, current-threshold relationship and the recovery of excitability following a supramaximal conditioning stimulus were recorded using threshold tracking. Compared with normal controls (n = 29), the axons of patients were of higher threshold. CMAPs and CSAPs were relatively small, although individual values remained within the normal ranges. Refractoriness and relative refractory period (markers of transient Na(+) channel function) were significantly reduced in GEFS+ patients with established mutations in SCN1B (P < 0.05), and strength-duration time constants (dependent on persistent Na(+) conductances) were reduced. It is suggested that, in peripheral nerve axons, the mutation underlying GEFS+ reduces the number of functioning Na(+) channels at the node of Ranvier and that this rather than any change in gating of individual channels dominates axonal excitability in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857929     DOI: 10.1093/brain/awh520

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

Review 1.  Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.

Authors:  Susanna B Park; Matthew C Kiernan; Steve Vucic
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

2.  Transient impairment of the axolemma following regional anaesthesia by lidocaine in humans.

Authors:  Mihai Moldovan; Kai Henrik Wiborg Lange; Niels Jacob Aachmann-Andersen; Troels Wesenberg Kjær; Niels Vidiendal Olsen; Christian Krarup
Journal:  J Physiol       Date:  2014-04-07       Impact factor: 5.182

3.  Persistent sodium current and its role in epilepsy.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2007 Jan-Feb       Impact factor: 7.500

4.  Axonal function in a family with episodic ataxia type 2 due to a novel mutation.

Authors:  Arun V Krishnan; Hugh Bostock; Jerome Ip; Michael Hayes; Shaun Watson; Matthew C Kiernan
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

Review 5.  Sodium channelopathies and pain.

Authors:  Angelika Lampert; Andrias O O'Reilly; Peter Reeh; Andreas Leffler
Journal:  Pflugers Arch       Date:  2010-01-26       Impact factor: 3.657

6.  Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.

Authors:  Susan E Tomlinson; S Veronica Tan; Dimitri M Kullmann; Robert C Griggs; David Burke; Michael G Hanna; Hugh Bostock
Journal:  Brain       Date:  2010-11-23       Impact factor: 13.501

7.  In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2.

Authors:  Susan E Tomlinson; S Veronica Tan; David Burke; Robyn W Labrum; Andrea Haworth; Vaneesha S Gibbons; Mary G Sweeney; Robert C Griggs; Dimitri M Kullmann; Hugh Bostock; Michael G Hanna
Journal:  Brain       Date:  2016-02       Impact factor: 13.501

8.  Defining the Functional Role of NaV1.7 in Human Nociception.

Authors:  Lucy A McDermott; Greg A Weir; Andreas C Themistocleous; Andrew R Segerdahl; Iulia Blesneac; Georgios Baskozos; Alex J Clark; Val Millar; Liam J Peck; Daniel Ebner; Irene Tracey; Jordi Serra; David L Bennett
Journal:  Neuron       Date:  2019-02-19       Impact factor: 17.173

9.  In vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission.

Authors:  Susan E Tomlinson; Hugh Bostock; Bronwyn Grinton; Michael G Hanna; Dimitri M Kullmann; Matthew C Kiernan; Ingrid E Scheffer; Samuel F Berkovic; David Burke
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

10.  Burning pain: axonal dysfunction in erythromelalgia.

Authors:  Michelle A Farrar; Ming-Jen Lee; James Howells; Peter I Andrews; Cindy S-Y Lin
Journal:  Pain       Date:  2017-05       Impact factor: 7.926

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.